Our MISSION is to improve the way value is measured and rewarded in the healthcare system.
Our GOAL is to promote the development and use of high value interventions that advance health.
The Value Debate
Scientific, technological, and clinical advances are driving a revolution in patient care – but spending on health care also continues to increase. Most observers agree that change is needed in order to link health care spending to value rather than volume, but determining how to make this link quickly leads to debate and disagreement. What defines value? Value to whom? And how do we measure it?
A New Approach
The Innovation and Value Initiative (IVI) was created to raise the level of discussion regarding value in health care and find common ground in the approach to measuring value. The U.S health system is diverse, complex, and ripe for innovation. IVI brings together health care leaders from academia, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and patient communities to advance approaches to value that fit the American context.
Patients are likely to continue to be asked to take more responsibility for their healthcare…it is time to shift the discussion toward helping patients understand what value actually means in choosing their health care and discharging their financial responsibilities.
Alan Balch and Darius Lakdawalla, Writing on the Health Affairs BlogLearn More
Latest News
How the Open Science Movement Creates Momentum for Value Assessment
In a Morning Consult commentary, IVI Executive Director, Jennifer Bright, discusses why transparency is a prerequisite to value-based reimbursement and how IVI's Open-Source Value Platform (OSVP) is an open laboratory for creating sophisticated systems to assess [...]
IVI’s Take on What’s In Store for Value Assessment in 2019
In an article published online by the American Journal of Managed Care, IVI's Executive Director, Jennifer Bright, and Director of Scientific Communications, Mark Linthicum, offer five predictions for where value assessment is headed in 2019. [...]
New IVI Research Shows Challenges with ICER Budget Impact Forecasting
IVI research into six pre-2016 ICER studies reveals an overestimation of “unmanaged” drug use and drug cost trends. The peer-reviewed research, published in Value in Health, illustrates the difficulty in predicting budget impact and the [...]
Value Frameworks Must Incorporate Real-World Evidence, Says Research Team Including IVI’s Darius Lakdawalla and Wayne Burton
In a new paper published by the American Journal of Managed Care, a team of researchers, including IVI's Darius Lakdawalla and Wayne Burton, conclude that key decision makers within our healthcare system need to recognize [...]